Global Connected Injectable Drug Delivery Devices Sales Market Report 2021
1 Connected Injectable Drug Delivery Devices Market Overview
- 1.1 Connected Injectable Drug Delivery Devices Product Scope
- 1.2 Connected Injectable Drug Delivery Devices Segment by Type
- 1.2.1 Global Connected Injectable Drug Delivery Devices Sales by Type (2016 & 2021 & 2027)
- 1.2.2 Conventional Injection Devices
- 1.2.3 Self-Injection Devices
- 1.2.4 Others
- 1.3 Connected Injectable Drug Delivery Devices Segment by Application
- 1.3.1 Global Connected Injectable Drug Delivery Devices Sales Comparison by Application (2016 & 2021 & 2027)
- 1.3.2 Diabetes
- 1.3.3 Cardiovascular Diseases
- 1.3.4 Autoimmune Diseases
- 1.3.5 Hormones Replacement
- 1.3.6 Neurology
- 1.3.7 Addiction
- 1.3.8 Respiratory Diseases
- 1.3.9 Others
- 1.4 Connected Injectable Drug Delivery Devices Market Estimates and Forecasts (2016-2027)
- 1.4.1 Global Connected Injectable Drug Delivery Devices Market Size in Value Growth Rate (2016-2027)
- 1.4.2 Global Connected Injectable Drug Delivery Devices Market Size in Volume Growth Rate (2016-2027)
- 1.4.3 Global Connected Injectable Drug Delivery Devices Price Trends (2016-2027)
2 Connected Injectable Drug Delivery Devices Estimates and Forecasts by Region
- 2.1 Global Connected Injectable Drug Delivery Devices Market Size by Region: 2016 VS 2021 VS 2027
- 2.2 Global Connected Injectable Drug Delivery Devices Retrospective Market Scenario by Region (2016-2021)
- 2.2.1 Global Connected Injectable Drug Delivery Devices Sales Market Share by Region (2016-2021)
- 2.2.2 Global Connected Injectable Drug Delivery Devices Revenue Market Share by Region (2016-2021)
- 2.3 Global Connected Injectable Drug Delivery Devices Market Estimates and Forecasts by Region (2022-2027)
- 2.3.1 Global Connected Injectable Drug Delivery Devices Sales Estimates and Forecasts by Region (2022-2027)
- 2.3.2 Global Connected Injectable Drug Delivery Devices Revenue Forecast by Region (2022-2027)
- 2.4 Geographic Market Analysis: Market Facts & Figures
- 2.4.1 North America Connected Injectable Drug Delivery Devices Estimates and Projections (2016-2027)
- 2.4.2 Europe Connected Injectable Drug Delivery Devices Estimates and Projections (2016-2027)
- 2.4.3 China Connected Injectable Drug Delivery Devices Estimates and Projections (2016-2027)
- 2.4.4 Japan Connected Injectable Drug Delivery Devices Estimates and Projections (2016-2027)
- 2.4.5 Southeast Asia Connected Injectable Drug Delivery Devices Estimates and Projections (2016-2027)
- 2.4.6 India Connected Injectable Drug Delivery Devices Estimates and Projections (2016-2027)
3 Global Connected Injectable Drug Delivery Devices Competition Landscape by Players
- 3.1 Global Top Connected Injectable Drug Delivery Devices Players by Sales (2016-2021)
- 3.2 Global Top Connected Injectable Drug Delivery Devices Players by Revenue (2016-2021)
- 3.3 Global Connected Injectable Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Connected Injectable Drug Delivery Devices as of 2020)
- 3.4 Global Connected Injectable Drug Delivery Devices Average Price by Company (2016-2021)
- 3.5 Manufacturers Connected Injectable Drug Delivery Devices Manufacturing Sites, Area Served, Product Type
- 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Connected Injectable Drug Delivery Devices Market Size by Type
- 4.1 Global Connected Injectable Drug Delivery Devices Historic Market Review by Type (2016-2021)
- 4.1.1 Global Connected Injectable Drug Delivery Devices Sales Market Share by Type (2016-2021)
- 4.1.2 Global Connected Injectable Drug Delivery Devices Revenue Market Share by Type (2016-2021)
- 4.1.3 Global Connected Injectable Drug Delivery Devices Price by Type (2016-2021)
- 4.2 Global Connected Injectable Drug Delivery Devices Market Estimates and Forecasts by Type (2022-2027)
- 4.2.1 Global Connected Injectable Drug Delivery Devices Sales Forecast by Type (2022-2027)
- 4.2.2 Global Connected Injectable Drug Delivery Devices Revenue Forecast by Type (2022-2027)
- 4.2.3 Global Connected Injectable Drug Delivery Devices Price Forecast by Type (2022-2027)
5 Global Connected Injectable Drug Delivery Devices Market Size by Application
- 5.1 Global Connected Injectable Drug Delivery Devices Historic Market Review by Application (2016-2021)
- 5.1.1 Global Connected Injectable Drug Delivery Devices Sales Market Share by Application (2016-2021)
- 5.1.2 Global Connected Injectable Drug Delivery Devices Revenue Market Share by Application (2016-2021)
- 5.1.3 Global Connected Injectable Drug Delivery Devices Price by Application (2016-2021)
- 5.2 Global Connected Injectable Drug Delivery Devices Market Estimates and Forecasts by Application (2022-2027)
- 5.2.1 Global Connected Injectable Drug Delivery Devices Sales Forecast by Application (2022-2027)
- 5.2.2 Global Connected Injectable Drug Delivery Devices Revenue Forecast by Application (2022-2027)
- 5.2.3 Global Connected Injectable Drug Delivery Devices Price Forecast by Application (2022-2027)
6 North America Connected Injectable Drug Delivery Devices Market Facts & Figures
- 6.1 North America Connected Injectable Drug Delivery Devices Sales by Company
- 6.1.1 North America Connected Injectable Drug Delivery Devices Sales by Company (2016-2021)
- 6.1.2 North America Connected Injectable Drug Delivery Devices Revenue by Company (2016-2021)
- 6.2 North America Connected Injectable Drug Delivery Devices Sales Breakdown by Type
- 6.2.1 North America Connected Injectable Drug Delivery Devices Sales Breakdown by Type (2016-2021)
- 6.2.2 North America Connected Injectable Drug Delivery Devices Sales Breakdown by Type (2022-2027)
- 6.3 North America Connected Injectable Drug Delivery Devices Sales Breakdown by Application
- 6.3.1 North America Connected Injectable Drug Delivery Devices Sales Breakdown by Application (2016-2021)
- 6.3.2 North America Connected Injectable Drug Delivery Devices Sales Breakdown by Application (2022-2027)
7 Europe Connected Injectable Drug Delivery Devices Market Facts & Figures
- 7.1 Europe Connected Injectable Drug Delivery Devices Sales by Company
- 7.1.1 Europe Connected Injectable Drug Delivery Devices Sales by Company (2016-2021)
- 7.1.2 Europe Connected Injectable Drug Delivery Devices Revenue by Company (2016-2021)
- 7.2 Europe Connected Injectable Drug Delivery Devices Sales Breakdown by Type
- 7.2.1 Europe Connected Injectable Drug Delivery Devices Sales Breakdown by Type (2016-2021)
- 7.2.2 Europe Connected Injectable Drug Delivery Devices Sales Breakdown by Type (2022-2027)
- 7.3 Europe Connected Injectable Drug Delivery Devices Sales Breakdown by Application
- 7.3.1 Europe 141 Sales Breakdown by Application (2016-2021)
- 7.3.2 Europe 141 Sales Breakdown by Application (2022-2027)
8 China Connected Injectable Drug Delivery Devices Market Facts & Figures
- 8.1 China Connected Injectable Drug Delivery Devices Sales by Company
- 8.1.1 China Connected Injectable Drug Delivery Devices Sales by Company (2016-2021)
- 8.1.2 China Connected Injectable Drug Delivery Devices Revenue by Company (2016-2021)
- 8.2 China Connected Injectable Drug Delivery Devices Sales Breakdown by Type
- 8.2.1 China Connected Injectable Drug Delivery Devices Sales Breakdown by Type (2016-2021)
- 8.2.2 China Connected Injectable Drug Delivery Devices Sales Breakdown by Type (2022-2027)
- 8.3 China Connected Injectable Drug Delivery Devices Sales Breakdown by Application
- 8.3.1 China 165 Sales Breakdown by Application (2016-2021)
- 8.3.2 China 165 Sales Breakdown by Application (2022-2027)
9 Japan Connected Injectable Drug Delivery Devices Market Facts & Figures
- 9.1 Japan Connected Injectable Drug Delivery Devices Sales by Company
- 9.1.1 Japan Connected Injectable Drug Delivery Devices Sales by Company (2016-2021)
- 9.1.2 Japan Connected Injectable Drug Delivery Devices Revenue by Company (2016-2021)
- 9.2 Japan Connected Injectable Drug Delivery Devices Sales Breakdown by Type
- 9.2.1 Japan Connected Injectable Drug Delivery Devices Sales Breakdown by Type (2016-2021)
- 9.2.2 Japan Connected Injectable Drug Delivery Devices Sales Breakdown by Type (2022-2027)
- 9.3 Japan Connected Injectable Drug Delivery Devices Sales Breakdown by Application
- 9.3.1 Japan Mar. Sales Breakdown by Application (2016-2021)
- 9.3.2 Japan Mar. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Connected Injectable Drug Delivery Devices Market Facts & Figures
- 10.1 Southeast Asia Connected Injectable Drug Delivery Devices Sales by Company
- 10.1.1 Southeast Asia Connected Injectable Drug Delivery Devices Sales by Company (2016-2021)
- 10.1.2 Southeast Asia Connected Injectable Drug Delivery Devices Revenue by Company (2016-2021)
- 10.2 Southeast Asia Connected Injectable Drug Delivery Devices Sales Breakdown by Type
- 10.2.1 Southeast Asia Connected Injectable Drug Delivery Devices Sales Breakdown by Type (2016-2021)
- 10.2.2 Southeast Asia Connected Injectable Drug Delivery Devices Sales Breakdown by Type (2022-2027)
- 10.3 Southeast Asia Connected Injectable Drug Delivery Devices Sales Breakdown by Application
- 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
- 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Connected Injectable Drug Delivery Devices Market Facts & Figures
- 11.1 India Connected Injectable Drug Delivery Devices Sales by Company
- 11.1.1 India Connected Injectable Drug Delivery Devices Sales by Company (2016-2021)
- 11.1.2 India Connected Injectable Drug Delivery Devices Revenue by Company (2016-2021)
- 11.2 India Connected Injectable Drug Delivery Devices Sales Breakdown by Type
- 11.2.1 India Connected Injectable Drug Delivery Devices Sales Breakdown by Type (2016-2021)
- 11.2.2 India Connected Injectable Drug Delivery Devices Sales Breakdown by Type (2022-2027)
- 11.3 India Connected Injectable Drug Delivery Devices Sales Breakdown by Application
- 11.3.1 India Connected Injectable Drug Delivery Devices Sales Breakdown by Application (2016-2021)
- 11.3.2 India Connected Injectable Drug Delivery Devices Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Connected Injectable Drug Delivery Devices Business
- 12.1 Phillips-Medisize
- 12.1.1 Phillips-Medisize Corporation Information
- 12.1.2 Phillips-Medisize Business Overview
- 12.1.3 Phillips-Medisize Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
- 12.1.4 Phillips-Medisize Connected Injectable Drug Delivery Devices Products Offered
- 12.1.5 Phillips-Medisize Recent Development
- 12.2 West Pharmaceutical Services
- 12.2.1 West Pharmaceutical Services Corporation Information
- 12.2.2 West Pharmaceutical Services Business Overview
- 12.2.3 West Pharmaceutical Services Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
- 12.2.4 West Pharmaceutical Services Connected Injectable Drug Delivery Devices Products Offered
- 12.2.5 West Pharmaceutical Services Recent Development
- 12.3 Biocorp
- 12.3.1 Biocorp Corporation Information
- 12.3.2 Biocorp Business Overview
- 12.3.3 Biocorp Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
- 12.3.4 Biocorp Connected Injectable Drug Delivery Devices Products Offered
- 12.3.5 Biocorp Recent Development
- 12.4 Aterica
- 12.4.1 Aterica Corporation Information
- 12.4.2 Aterica Business Overview
- 12.4.3 Aterica Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
- 12.4.4 Aterica Connected Injectable Drug Delivery Devices Products Offered
- 12.4.5 Aterica Recent Development
- 12.5 Unilife
- 12.5.1 Unilife Corporation Information
- 12.5.2 Unilife Business Overview
- 12.5.3 Unilife Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
- 12.5.4 Unilife Connected Injectable Drug Delivery Devices Products Offered
- 12.5.5 Unilife Recent Development
- 12.6 Propeller Health
- 12.6.1 Propeller Health Corporation Information
- 12.6.2 Propeller Health Business Overview
- 12.6.3 Propeller Health Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
- 12.6.4 Propeller Health Connected Injectable Drug Delivery Devices Products Offered
- 12.6.5 Propeller Health Recent Development
- 12.7 Haselmeier
- 12.7.1 Haselmeier Corporation Information
- 12.7.2 Haselmeier Business Overview
- 12.7.3 Haselmeier Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
- 12.7.4 Haselmeier Connected Injectable Drug Delivery Devices Products Offered
- 12.7.5 Haselmeier Recent Development
- 12.8 SHL
- 12.8.1 SHL Corporation Information
- 12.8.2 SHL Business Overview
- 12.8.3 SHL Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
- 12.8.4 SHL Connected Injectable Drug Delivery Devices Products Offered
- 12.8.5 SHL Recent Development
- 12.9 Becton Dickinson
- 12.9.1 Becton Dickinson Corporation Information
- 12.9.2 Becton Dickinson Business Overview
- 12.9.3 Becton Dickinson Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
- 12.9.4 Becton Dickinson Connected Injectable Drug Delivery Devices Products Offered
- 12.9.5 Becton Dickinson Recent Development
- 12.10 Baxter International
- 12.10.1 Baxter International Corporation Information
- 12.10.2 Baxter International Business Overview
- 12.10.3 Baxter International Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
- 12.10.4 Baxter International Connected Injectable Drug Delivery Devices Products Offered
- 12.10.5 Baxter International Recent Development
- 12.11 Scandinavian Health
- 12.11.1 Scandinavian Health Corporation Information
- 12.11.2 Scandinavian Health Business Overview
- 12.11.3 Scandinavian Health Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
- 12.11.4 Scandinavian Health Connected Injectable Drug Delivery Devices Products Offered
- 12.11.5 Scandinavian Health Recent Development
- 12.12 Ypsomed
- 12.12.1 Ypsomed Corporation Information
- 12.12.2 Ypsomed Business Overview
- 12.12.3 Ypsomed Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
- 12.12.4 Ypsomed Connected Injectable Drug Delivery Devices Products Offered
- 12.12.5 Ypsomed Recent Development
- 12.13 Terumo Medical
- 12.13.1 Terumo Medical Corporation Information
- 12.13.2 Terumo Medical Business Overview
- 12.13.3 Terumo Medical Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
- 12.13.4 Terumo Medical Connected Injectable Drug Delivery Devices Products Offered
- 12.13.5 Terumo Medical Recent Development
- 12.14 Schott
- 12.14.1 Schott Corporation Information
- 12.14.2 Schott Business Overview
- 12.14.3 Schott Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
- 12.14.4 Schott Connected Injectable Drug Delivery Devices Products Offered
- 12.14.5 Schott Recent Development
- 12.15 Owen Mumford
- 12.15.1 Owen Mumford Corporation Information
- 12.15.2 Owen Mumford Business Overview
- 12.15.3 Owen Mumford Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
- 12.15.4 Owen Mumford Connected Injectable Drug Delivery Devices Products Offered
- 12.15.5 Owen Mumford Recent Development
- 12.16 Antares Pharma
- 12.16.1 Antares Pharma Corporation Information
- 12.16.2 Antares Pharma Business Overview
- 12.16.3 Antares Pharma Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
- 12.16.4 Antares Pharma Connected Injectable Drug Delivery Devices Products Offered
- 12.16.5 Antares Pharma Recent Development
- 12.17 Zogenix
- 12.17.1 Zogenix Corporation Information
- 12.17.2 Zogenix Business Overview
- 12.17.3 Zogenix Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
- 12.17.4 Zogenix Connected Injectable Drug Delivery Devices Products Offered
- 12.17.5 Zogenix Recent Development
13 Connected Injectable Drug Delivery Devices Manufacturing Cost Analysis
- 13.1 Connected Injectable Drug Delivery Devices Key Raw Materials Analysis
- 13.1.1 Key Raw Materials
- 13.1.2 Key Raw Materials Price Trend
- 13.1.3 Key Suppliers of Raw Materials
- 13.2 Proportion of Manufacturing Cost Structure
- 13.3 Manufacturing Process Analysis of Connected Injectable Drug Delivery Devices
- 13.4 Connected Injectable Drug Delivery Devices Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
- 14.1 Marketing Channel
- 14.2 Connected Injectable Drug Delivery Devices Distributors List
- 14.3 Connected Injectable Drug Delivery Devices Customers
15 Market Dynamics
- 15.1 Connected Injectable Drug Delivery Devices Market Trends
- 15.2 Connected Injectable Drug Delivery Devices Drivers
- 15.3 Connected Injectable Drug Delivery Devices Market Challenges
- 15.4 Connected Injectable Drug Delivery Devices Market Restraints
16 Research Findings and Conclusion
17 Appendix
- 17.1 Research Methodology
- 17.1.1 Methodology/Research Approach
- 17.1.2 Data Source
- 17.2 Author List
The global Connected Injectable Drug Delivery Devices market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Connected Injectable Drug Delivery Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Conventional Injection Devices
Self-Injection Devices
Others
Segment by Application
Diabetes
Cardiovascular Diseases
Autoimmune Diseases
Hormones Replacement
Neurology
Addiction
Respiratory Diseases
Others
The Connected Injectable Drug Delivery Devices market is analysed and market size information is provided by regions (countries). Segment by Application, the Connected Injectable Drug Delivery Devices market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Phillips-Medisize
West Pharmaceutical Services
Biocorp
Aterica
Unilife
Propeller Health
Haselmeier
SHL
Becton Dickinson
Baxter International
Scandinavian Health
Ypsomed
Terumo Medical
Schott
Owen Mumford
Antares Pharma
Zogenix